Table 4.
All primary cancers (C00-C97) | Prostate cancer (C61) | Malignant melanoma (C43) | |||||||
---|---|---|---|---|---|---|---|---|---|
Exposure | No | Yes | No | Yes | No | Yes | |||
metrics | n = 474 | n = 77 | RR (95% CI) | n = 524 | n = 27 | RR (95% CI) | n = 544 | n = 7 | RR (95% CI) |
Employment years | |||||||||
Unexposed | 232 | 33 | 1.00 (Referent) | 253 | 12 | 1.00 (Referent) | 264 | 1 | 1.00 (Referent) |
<15 | 127 | 5 | 1.73 (0.51 to 5.18) | 132 | 0 | − | 131 | 1 | 9.33 (0.22 to 596.01) |
15+ | 115 | 39 | 2.34 (1.45 to 3.80) | 139 | 15 | 2.40 (1.10 to 5.23) | 149 | 5 | 9.55 (1.49 to 187.47) |
p-trend | 0.002 | 0.05 | 0.02 | ||||||
Cumulative air hours | |||||||||
Unexposed | 232 | 33 | 1.00 (Referent) | 253 | 12 | 1.00 (Referent) | 264 | 1 | 1.00 (Referent) |
<10,000 | 163 | 7 | 1.40 (0.49 to 3.73) | 170 | 0 | − | 169 | 1 | 3.27 (0.09 to 160.46) |
10,000+ | 79 | 37 | 2.41 (1.50 to 3.90) | 101 | 15 | 2.61 (1.22 to 5.60) | 111 | 5 | 10.29 (1.66 to 197.12) |
p-trend | 0.0001 | 0.01 | 0.004 | ||||||
Cumulative mSv | |||||||||
Unexposed | 232 | 33 | 1.00 (Referent) | 253 | 12 | 1.00 (Referent) | 264 | 1 | 1.00 (Referent) |
<25 | 145 | 6 | 1.36 (0.46 to 3.56) | 151 | 0 | − | 150 | 1 | 5.07 (0.14 to 201.23) |
25+ | 97 | 38 | 2.42 (1.50 to 3.92) | 120 | 15 | 2.57 (1.18 to 5.56) | 130 | 5 | 9.88 (1.57 to 190.78) |
p-trend | 0.0005 | 0.02 | 0.009 | ||||||
Cumulative mSv up to age of 40 years | |||||||||
Unexposed | 232 | 33 | 1.00 (Referent) | 253 | 12 | 1.00 (Referent) | 264 | 1 | 1.00 (Referent) |
<5 | 120 | 5 | 1.53 (0.47 to 4.20) | 125 | 0 | − | 125 | 0 | − |
5+ | 122 | 39 | 2.37 (1.47 to 3.85) | 146 | 15 | 2.47 (1.13 to 5.41) | 155 | 6 | 10.34 (1.23 to 86.61) |
p-trend | 0.003 | 0.06 | 0.005 |
Abbreviations: MilliSievert (mSv), relative risk (RR), confidence interval (CI)